Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top Biotech and Pharma Deals in April 2018
Insofar as pharma M&As are concerned, 2018 is turning out to be a milestone year with more than
Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion
The New
Year began with the JP Morgan Healthcare Conference— the drug industry’s annual
FDA’s Drug Approvals in 2015: Novel Drugs & New Versions of Existing Drugs
Each year,
the US Food and Drug Administration (FDA) approve hundreds
of new medications. A small su